Quality key factors
Factor
Value
Sales Growth (5y)
-31.57%
EBIT Growth (5y)
-229.91%
EBIT to Interest (avg)
-3.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.65
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.96%
ROE (avg)
0.52%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.86
EV to EBIT
-7.58
EV to EBITDA
-7.58
EV to Capital Employed
3.97
EV to Sales
5.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.44%
ROE (Latest)
-27.48%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Biohit Oyj
Net Sales - Half-Yearly
At EUR 7 MM has Grown at 37.50 %
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (EUR MM)
Net Sales - Half-Yearly
Highest at EUR 7 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Cash and Cash Equivalents - Half Yearly
Highest at EUR 3.03 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (EUR MM)






